Rino Ferrarese is the COO and co-founder of CTPharma, a biotech company with clinical stage and discovery assets derived from cannabis. In 2019, CTPharma announced its FDA-approved IND trial in collaboration with Yale School of Medicine. CTPharma currently manufactures premium cannabis products across twenty-five categories and will complete construction of a new 216,000 square foot facility in 2020.
Rino has experience working as a compliance officer working in FDA-regulated industries under current Good Manufacturing Practices (cGMPs) for prescription, OTC and homeopathic drug products. He is a certified Six Sigma Black Belt (ASQ) and an ISO auditor. He has worked with clients across the United States to secure cannabis licenses in competitive bid applications. Mr. Ferrarese speaks nationally on topics related to cannabis and co-authors columns for the Cannabis Business Times.